Aptevo Therapeutics Inc. (APVO) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$4.96
+0.81%
Mkt Cap $10.82M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 20, 2026 | — | — | — | -$8.09 | $1684.47 | +20921.63% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$37.59 | -$40.11 | -6.70% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.45 | -$151.08 | -33473.33% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$1514.39 | -$1579.14 | -4.28% | — | — |
| Q1 2025 Mar 4, 2025 | — | — | — | -$7.75 | -$82.37 | -962.84% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$7428.84 | -$6255.86 | +15.79% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$25153.80 | -$21765.20 | +13.47% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$183766.00 | -$129679.00 | +29.43% | — | — |
| Q1 2024 Mar 5, 2024 | — | — | — | -$18.04 | -$6.16 | +65.85% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$413383.00 | -$287072.00 | +30.56% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$643040.00 | -$706196.00 | -9.82% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$683230.00 | $149277.00 | +121.85% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$1.53 | -$0.95 | +37.91% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$941595.00 | -$878439.00 | +6.71% | — | — |
| Q3 2022 Aug 11, 2022 | $3.45M | — | — | -$763610.00 | -$1067910.00 | -39.85% | — | — |
| Q2 2022 May 12, 2022 | $3.75M | $3.11M | -16.96% | -$660265.00 | -$912888.00 | -38.26% | — | — |
| Q1 2022 Mar 24, 2022 | $3.40M | $3.67M | +7.79% | -$1.29 | -$1.27 | +1.55% | — | — |
| Q4 2021 Nov 12, 2021 | $3.16M | $3.10M | -1.99% | -$849732.00 | -$832508.00 | +2.03% | — | — |
| Q3 2021 Aug 12, 2021 | $900.00K | $3.11M | +245.56% | -$1119580.00 | -$1021970.00 | +8.72% | — | — |
| Q2 2021 May 11, 2021 | $6.47M | $2.42M | -62.59% | -$930112.00 | -$999009.00 | -7.41% | — | — |
| Q1 2021 Mar 31, 2021 | — | $2.37M | — | -$1.22 | -$1.92 | -57.38% | — | — |
| Q4 2020 Nov 10, 2020 | $1.40M | $1.46M | +4.69% | -$1176990.00 | -$1234410.00 | -4.88% | — | — |
| Q3 2020 Aug 14, 2020 | $463.99K | $473.00K | +1.94% | -$1303310.00 | -$1205700.00 | +7.49% | — | — |
| Q2 2020 May 13, 2020 | — | — | — | -$1464070.00 | -$1389430.00 | +5.10% | — | — |
| Q1 2020 Mar 25, 2020 | $13.62M | $9.03M | -33.70% | -$3.59 | -$2.38 | +33.70% | — | — |
| Q4 2019 Nov 7, 2019 | $13.52M | $9.01M | -33.33% | -$1929890.00 | -$1849480.00 | +4.17% | — | — |
| Q3 2019 Aug 9, 2019 | $8.10M | $7.36M | -9.09% | -$3055660.00 | -$2412370.00 | +21.05% | — | — |
| Q2 2019 May 9, 2019 | $7.02M | $7.02M | +0.00% | -$3859790.00 | -$3538140.00 | +8.33% | — | — |
| Q1 2019 Mar 18, 2019 | $5.46M | $6.35M | +16.20% | -$7.47 | -$8.68 | -16.20% | — | — |
| Q4 2018 Nov 14, 2018 | $5.97M | $5.82M | -2.37% | -$4744320.00 | -$4503080.00 | +5.08% | — | — |
| Q3 2018 Aug 9, 2018 | $7.59M | $6.83M | -10.08% | -$5226790.00 | -$4663910.00 | +10.77% | — | — |
| Q2 2018 May 10, 2018 | $3.59M | $4.07M | +13.51% | -$4503080.00 | -$5065970.00 | -12.50% | — | — |
| Q1 2018 Mar 13, 2018 | $1.96M | $2.82M | +43.75% | -$4.48 | -$6.44 | -43.75% | — | — |
| Q4 2017 Nov 9, 2017 | $7.85M | $6.17M | -21.33% | $18092700.00 | $1125770.00 | -93.78% | — | — |
| Q3 2017 Aug 10, 2017 | — | $10.76M | — | — | -$4261850.00 | — | — | — |
| Q2 2017 May 12, 2017 | $10.96M | $7.41M | -32.39% | -$5709270.00 | -$3859790.00 | +32.39% | — | — |
| Q1 2017 Mar 31, 2017 | $385.84M | $8.77M | -97.73% | -$0.44 | $80412.20 | +18275600.00% | — | — |
| Q4 2016 Nov 14, 2016 | $7.62M | $9.40M | +23.44% | -$5146380.00 | -$6432980.00 | -25.00% | — | — |
| Q3 2016 Aug 26, 2016 | — | $10.19M | — | — | -$289418.00 | — | — | — |
| Q1 2016 Mar 31, 2016 | — | $8.07M | — | — | -$266541.00 | — | — | — |
| Q4 2015 Dec 31, 2015 | — | $8.29M | — | — | -$403293.00 | — | — | — |
| Q3 2015 Sep 30, 2015 | — | $6.56M | — | — | -$285716.00 | — | — | — |
| Q2 2015 Jun 30, 2015 | — | $7.09M | — | — | -$399192.00 | — | — | — |
| Q1 2015 Mar 31, 2015 | — | $11.66M | — | — | -$248357.00 | — | — | — |